Clinical course and prognostic factors following bone recurrence from breast cancer (Q34065927)

30 July 2017

title

Clinical course and prognostic factors following bone recurrence from breast cancer (English)

1 reference

30 July 2017

1 reference

R. E. Coleman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9461007

6 December 2024

P. Smith

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9461007

6 December 2024

R. D. Rubens

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9461007

6 December 2024

language of work or name

English

0 references

publication date

1 January 1998

1 reference

30 July 2017

1998

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9461007

full work available at URL

6 December 2024

https://europepmc.org/articles/pmc2151240?pdf=render

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9461007

https://europepmc.org/articles/PMC2151240

6 December 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9461007

https://europepmc.org/articles/PMC2151240?pdf=render

6 December 2024

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9461007

http://www.nature.com/articles/bjc199852.pdf

6 December 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/BJC.1998.52

http://www.nature.com/articles/bjc199852

6 December 2024

1 reference

https://api.crossref.org/works/10.1038/BJC.1998.52

British Journal of Cancer

6 December 2024

published in

1 reference

30 July 2017

volume

77

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

336-340

1 reference

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151240

Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151240

Use of bisphosphonates in cancer patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151240

Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151240

High-dose intravenous pamidronate for metastatic bone pain

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151240

The clinical course of bone metastases from breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151240

Bone metastases: pathogenesis, treatment, and rationale for use of resorption inhibitors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151240

Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasis. The Breast Cancer Study Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151240

Localization of parathyroid hormone-related protein mRNA expression in breast cancer and metastatic lesions by in situ hybridization

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151240

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151240

Parathyroid hormone related protein and skeletal morbidity in breast cancer

5 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9461007

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9461007

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9461007

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.1998.52

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference